NASDAQ: ORMP

Israel-based drug developer Oramed Pharmaceuticals Inc., (NASDAQ: ORMP) has revealed that a deal has been signed with its existing China-based partner, Hefei Tianhui Biotech Co., Ltd (HTIT), to establish a joint venture (JV). The non-binding term sheet signed by both parties outlines that the JV will focus on the development…